Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer

Chao Xu,Xiao-Li Xie,Ning Kang,Hui-Qing Jiang
DOI: https://doi.org/10.1186/s12876-023-02930-0
2023-09-06
BMC Gastroenterology
Abstract:Gastric cancer (CC) is a disease with high incidence and mortality rate. Immunotherapy is an important method for gastric cancer while lack of effective predictor. Integrins play an important role in the development. We aimed to explore the predictive value of β1 integrin (ITGB1) as a predictor of immunnotherapy in gastric cancer.
gastroenterology & hepatology
What problem does this paper attempt to address?